rs12721636
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_017460.6(CYP3A4):c.-62C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00101 in 1,492,528 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00093 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0010 ( 13 hom. )
Consequence
CYP3A4
NM_017460.6 5_prime_UTR
NM_017460.6 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.728
Publications
5 publications found
Genes affected
CYP3A4 (HGNC:2637): (cytochrome P450 family 3 subfamily A member 4) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020]
CYP3A4 Gene-Disease associations (from GenCC):
- vitamin D-dependent rickets, type 3Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00102 (1372/1340264) while in subpopulation MID AF = 0.0291 (160/5502). AF 95% confidence interval is 0.0254. There are 13 homozygotes in GnomAdExome4. There are 707 alleles in the male GnomAdExome4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High AC in GnomAd4 at 141 Unknown,AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000920 AC: 140AN: 152146Hom.: 1 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
140
AN:
152146
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00102 AC: 1372AN: 1340264Hom.: 13 Cov.: 21 AF XY: 0.00105 AC XY: 707AN XY: 673610 show subpopulations
GnomAD4 exome
AF:
AC:
1372
AN:
1340264
Hom.:
Cov.:
21
AF XY:
AC XY:
707
AN XY:
673610
show subpopulations
African (AFR)
AF:
AC:
29
AN:
31088
American (AMR)
AF:
AC:
70
AN:
44272
Ashkenazi Jewish (ASJ)
AF:
AC:
120
AN:
25258
East Asian (EAS)
AF:
AC:
0
AN:
38836
South Asian (SAS)
AF:
AC:
81
AN:
83512
European-Finnish (FIN)
AF:
AC:
2
AN:
52904
Middle Eastern (MID)
AF:
AC:
160
AN:
5502
European-Non Finnish (NFE)
AF:
AC:
775
AN:
1002714
Other (OTH)
AF:
AC:
135
AN:
56178
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
67
135
202
270
337
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000926 AC: 141AN: 152264Hom.: 1 Cov.: 31 AF XY: 0.000913 AC XY: 68AN XY: 74468 show subpopulations
GnomAD4 genome
AF:
AC:
141
AN:
152264
Hom.:
Cov.:
31
AF XY:
AC XY:
68
AN XY:
74468
show subpopulations
African (AFR)
AF:
AC:
11
AN:
41544
American (AMR)
AF:
AC:
30
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
18
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5180
South Asian (SAS)
AF:
AC:
5
AN:
4818
European-Finnish (FIN)
AF:
AC:
2
AN:
10618
Middle Eastern (MID)
AF:
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
AC:
58
AN:
68018
Other (OTH)
AF:
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.